Request a Demo

Irix

Risk Score | Morbidity

Take a larger share of the Medicare Supplement market.

Get a real-time snapshot of individual health risk in seconds.

The predictive model that revolutionized underwriting with a simple numerical score is now being used to instantly assess morbidity in Medicare Supplement applicants.

Upend the status quo and take a larger share of the highly competitive Medicare Supplement market with Risk Score. Using a single risk metric, you’ll find efficiencies and cost-savings that fight back against rate compression and increasing loss ratios. And with Risk Score’s predictive accuracy, you’ll pay less in claims and improve profitability. Retrospective studies show astounding benefit-to-cost figures.

What you may be missing without Risk Score

  • Better risk selection
  • The ability to issue more underwritten business
  • Optimized policy pricing
  • Decreased decline rates
  • Automated decisioning

See the bigger picture with Risk Score

Risk Score consistently interprets the combination of prescription histories and medical claims data to predict morbidity with rapid-fire speed and proven accuracy. It stratifies risk within a given medical condition, detects unintuitive patterns you might otherwise miss, and brings ease to point-of-sale decisions. You can confidently select the best risks in just moments.

Request a demo

    true

    Get ahead of the Medicare Supplement market now.

    Talk to us about a proof-of-concept study to see how it can bring unprecedented value to your Medicare Supplement business.

    Related topics

    From uninsurable to opportunity: The evolving mortality of hepatitis C, HIV, and cystic fibrosis

    Webinar

    From uninsurable to opportunity: The evolving mortality of hepatitis C, HIV, and cystic fibrosis

    Underwriting is an ever-changing, highly nuanced discipline—and guidelines must keep up.

    Read more
    Munich RE’s retro study compares EHR data to traditional fluids in fully underwritten scenarios and concludes, “Why not try EHR first?”

    White Paper

    Study: EHR beats insurance exams and labs

    Munich RE’s retro study compares EHR data to traditional fluids in fully underwritten scenarios and concludes, “Why not try...

    Read more
    Recent FDA-approved drugs of interest to underwriters

    Article

    Recent FDA-approved drugs of interest to underwriters

    Understand their health implications so you can confidently assess risk.

    Read more